GLP-1 receptor agonist solutions for once-daily subcutaneous injection in diabetes and obesity management. Used in clinical settings such as internal medicine wards, specialty clinics, and community health centers by endocrinologists. Acquired from drug manufacturers through supply chains to medical institutions